GREENLAND MINES LTD Payments to Acquire Investments
GREENLAND MINES LTD (GRML) reported Payments to Acquire Investments of $476.47 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-17
- GREENLAND MINES LTD payments to acquire investments for the quarter ending 2026-06-30 was $111.15K.
- GREENLAND MINES LTD payments to acquire investments for the quarter ending 2026-03-31 was $365.32K.
- GREENLAND MINES LTD payments to acquire investments for the quarter ending 2024-12-31 was $0.00.
- GREENLAND MINES LTD payments to acquire investments for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- GREENLAND MINES LTD payments to acquire investments for fiscal 2024 was $123.50K, a 789.24% increase from fiscal 2023.
- GREENLAND MINES LTD payments to acquire investments for fiscal 2023 was $13.89K, a 99.99% decline from fiscal 2022.
- GREENLAND MINES LTD payments to acquire investments for fiscal 2022 was $116.15M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $111.15K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-17 | $476.47K 10-Q · filed 2026-08-17 | ||
| 2026-03-31 | $365.32K 10-Q/A · filed 2026-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $1.00 derived: sum of 3 quarters · filed 2026-08-14 | $123.50K 10-K/A · filed 2026-08-14 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.00 derived: sum of 2 quarters · filed 2025-11-13 | $123.50K 10-Q · filed 2025-11-13 | $71.06K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $123.50K 10-Q · filed 2025-08-18 | $71.06K derived: sum of 3 quarters · filed 2025-08-18 | $127.39K derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | $123.50K 10-Q · filed 2025-05-15 | $71.06K derived: sum of 2 quarters · filed 2025-05-15 | $127.38K derived: sum of 3 quarters · filed 2025-05-15 | -$222.62K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$52.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.89K derived: sum of 2 quarters · filed 2025-03-31 | -$346.11K derived: sum of 3 quarters · filed 2025-03-31 | $13.89K 10-K · filed 2025-03-31 |
| 2023-09-30 | $56.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$293.68K derived: sum of 2 quarters · filed 2024-11-19 | $66.33K 10-Q · filed 2024-11-19 | $66.33K derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | -$350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $10.00K 10-Q · filed 2024-08-19 | $10.00K derived: sum of 3 quarters · filed 2024-08-19 | $10.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $360.00K 10-Q · filed 2023-05-24 | $360.00K derived: sum of 2 quarters · filed 2024-04-17 | $360.00K derived: sum of 3 quarters · filed 2024-04-17 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $0.00 derived: sum of 2 quarters · filed 2024-04-17 | $116.15M 10-K · filed 2024-04-17 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $116.15M 10-Q · filed 2023-11-17 | ||
| 2022-06-30 | $116.15M 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |